Garner Biosolutions

Founded in 2017 and headquartered in Cambridge, Massachusetts, Garner Biosolutions is a private company addressing the growing challenge of sourcing reliable human biospecimens for the life sciences industry. It has established a global network of approved providers, including hospitals, biobanks, and academic institutions, primarily in Asia and Europe, to supply thousands of samples daily with short wait times and pre-established compliance protocols. The company's business model is service-oriented, generating revenue by facilitating access to these critical research materials. Its value proposition centers on ethical sourcing, rigorous quality control, and adherence to US and international regulatory frameworks.

Operational and logistical platform for global biospecimen procurement, comprising a vetted provider network, compliance and provenance tracking systems, and global logistics management.

Garner competes in a fragmented market with large, established biospecimen vendors and numerous niche brokers. Its differentiation is based on a curated global network, strong emphasis on pre-established US compliance standards, and a client-centric 'your way' procurement model.